We lead advocacy efforts that support research and access to care for our high risk Veterans.
Burn Pits Accountability Act
The act is a first step to ensure that all those effected by burn pit toxins are accounted for and to ensure that steps are taken to address associated health issues. Because lung cancer has a disproportionately higher impact on Veterans than the civilian population, especially those exposed to carcinogens during active duty service. Click here to learn more.
Lung Cancer Research Program within the Congressional Directed Medical Research Program administered by the Department of Defense (DOD)
Established in 2008 by GO2 advocacy efforts to prioritize research for our high risk military men and women, the program has provided a total of $155.5 million in funding over the past ten years (FY09-FY19), making it the largest lung cancer research program – public or private – outside of the National Cancer Institute (NCI) at the National Institute of Health (NIH). Research studies include biomarkers of disease recurrence, cutting edge immunotherapies, targeted tests and treatments with added emphasis on under-researched small cell lung cancer. Click here to learn more.
VALOR
We are engaged with and support the VALOR (Veterans Affairs Lung Cancer or Stereotactic Radiotherapy) trial to recruit early stage patients from multiple VA Medical Centers across the country. Patients who participate in this trial will be treated randomly with either surgery or stereotactic radiotherapy. Doctors will then follow these patients for many years to see if there is any difference in how well the treatments work against their cancer. The study is led by Drew Moghanaki, MD, who is a member of our Scientific Leadership Board, as well as Tomer Karas, MD. Click here to learn more.